Aimafix (Human Coagulation Factor Ix)

Aimafix is a pharmaceutical product containing Human Coagulation Factor IX, used for managing bleeding disorders. This intravenous medication supports clotting and is manufactured by Kedrion S.P.A.

Aimafix is primarily used to control bleeding episodes in individuals with certain clotting disorders. It works by replacing the missing clotting factor, helping the blood to clot more effectively. This medication is often prescribed for conditions where the body does not produce enough Factor IX.

When administered intravenously, Aimafix helps to stabilize blood clotting processes. Users may experience improved control over bleeding episodes, though individual responses can vary. Common effects include a reduction in bleeding frequency and severity.

Aimafix should be handled with care, following medical guidelines for storage and administration. It is essential to use this medication under the supervision of a healthcare professional. Always check for any signs of contamination or damage before use.

Aimafix may interact with other medications that affect blood clotting. It is important to inform your healthcare provider about all medications you are taking. Avoid using Aimafix with substances that can increase the risk of bleeding or clotting disorders.